- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imaging stocks continue to struggle
Public companies providing imaging devices and services continue to have a hard time making money for their shareholders, according to data from a recent industry survey by HealthCare Markets Group. Shares of imaging device manufacturers fell 4.6% in the
Public companies providing imaging devices and services continue to have a hard time making money for their shareholders, according to data from a recent industry survey by HealthCare Markets Group. Shares of imaging device manufacturers fell 4.6% in the first nine months of 1999 (end-September), compared to a 21% drop for the same period in 1998.
Among the biggest gainers were Vital Images, up 170%, and SonoSite, up 152%; the biggest losses were felt by Hologic, down 67%, and Fischer Imaging, down 56%.
Share price for imaging services vendors declined 5.8% during the first nine months of 1999, compared to a 32% decline for all of 1998. Overall, healthcare industry stock prices declined 2.8% in the first nine months of 1999, compared to a 1.9% increase in the same period of 1998.
Despite the poor performance, 1999 is still turning out to be a better year than 1998, which witnessed a 23% decline in share value for imaging device firms (SCAN 1/13/99). HMG of Hilton Head, SC, reviews the financial performance of publicly owned healthcare companies in 36 market segments.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
